Acute megakaryoblastic leukaemia in Down syndrome and non-Down syndrome patients - molecular signature of a disease - subtypes with distinct treatment outcomes

Gelijkaardige items

• Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.
  door: Roy, A, et al.
  Gepubliceerd in: (2009)
• Infantile acute megakaryoblastic leukaemia with T(1:22) in a non-down syndrome child.
  door: Nurasyikin Y,, et al.
  Gepubliceerd in: (2012)
• Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome
  door: Tunstall, O, et al.
  Gepubliceerd in: (2018)
• Improved outcome of acute myeloid leukaemia in Down's syndrome.
  door: Craze, J, et al.
  Gepubliceerd in: (1999)
• Haematopoietic development and leukaemia in Down syndrome
  door: Roberts, I, et al.
  Gepubliceerd in: (2014)